CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,023,010
- in 6 filings, $3.0M under 10b5-1 plans
Net −$3,023,010. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Barrow Robert −$1.9M Chief Executive Officer sold 2% of stake
- Sullivan Mark −$514K Chief Legal Officer sold 3% of stake
- Karlin Daniel −$397K Chief Medical Officer sold 1% of stake
- Roberts Brandi −$123K Chief Financial Officer sold <1% of stake
- Wiley Matthew T. −$113K Chief Commercial Officer sold <1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −31,550 | $36.57 | $1.2M | 2,213,090 |
| 2026-09-14 | Barrow Robert Chief Executive Officer | Grant or award | +750,000 | 2,244,640 | ||
| 2026-09-03 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −19,023 | $37.94 | $722K | 1,494,640 |
| 2026-09-02 | Barrow Robert Chief Executive Officer | Grant or award 10b5-1 | +40,000 | 1,513,663 | ||
| 2026-08-12 | Barrow Robert Chief Executive Officer | Grant or award | +375,000 | 1,473,246 | ||
| 2026-06-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −29,208 | $45.03 | $1.3M | 1,098,246 |
| 2026-06-22 | Barrow Robert Chief Executive Officer | Grant or award | +375,000 | 1,127,454 | ||
| 2026-03-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −24,431 | $18.47 | $451K | 752,454 |
| 2026-02-03 | Barrow Robert Chief Executive Officer | Grant or award | +320,000 | 1,098,477 | ||
| 2025-12-26 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −25,791 | $13.15 | $339K | 778,477 |
| 2025-09-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −25,797 | $9.77 | $252K | 804,268 |
| 2025-06-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −26,491 | $6.80 | $180K | 830,065 |
| 2025-03-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −21,208 | $6.74 | $143K | 856,556 |
| 2025-03-12 | Barrow Robert Chief Executive Officer | Grant or award | +350,000 | 877,764 | ||
| 2024-12-26 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −19,106 | $7.43 | $142K | 526,666 |
| 2024-09-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −19,771 | $5.98 | $118K | 545,772 |
| 2024-08-20 | Barrow Robert Chief Executive Officer | Purchase | +500 | $6.12 | $3K | 565,543 |
| 2024-08-19 | Barrow Robert Chief Executive Officer | Purchase | +500 | $6.31 | $3K | 565,043 |
| 2024-06-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −15,659 | $7.22 | $113K | 564,543 |
| 2024-03-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −16,519 | $9.50 | $157K | 580,202 |
Page 1 of 3 · 48 trades